biotechnology Amyris Inc. (NASDAQ: AMRS) is a biotechnology company that develops alternative products for beauty, skincare, and the food industry. This company closely aligns with portfolios focused on clean energy and renewables. With brands like Biossance, Amyris biotechnology aims to bring naturally-derived and highly engineered ingredients to key industries. Its progress in ethical and renewable cosmetic ingredients is impressive.

Revenue growth has been equally impressive. In 2015, Amyris generated $34.15 million in the fiscal year. By 2019, that figure had increased to $152.56 million. High spending on research and development means that the company is yet to achieve profitability on the bottom line. The gross profit margin is 50.06%, while the EBITDA margin is -68.50%. The company has the funding to continue its growth, which means there’s flexibility for it to maintain operations as it works towards a positive turnover.

Analysts are confident in this stock. It appeals to the alternative market because it is affordable and focused on popular ethical and ‘green’ products. Most importantly for investors today, there’s a strong upside predicted, with an average target price of $10.00. For its upside and potential in the cosmetic and beauty markets, this is an alternative pick for June.

Key Data:

  • 1 Year Price Growth: 37%
  • YTD Price Growth: 81%
  • 3 Month Price Growth: 26%

All information is based on current and historical market data, as well as publicly available financial data. As with any financial decision, your own research is important. Stock market outcomes can never be 100% accurately predicted. Familiarity with historical data, individual industries, and individual stocks is key to developing a robust portfolio. Note that stock prices can fluctuate rapidly during trading sessions.